Belge G, Thode B, Bullerdiek J, Bartnitzke S
Center of Human Genetics and Genetic Counselling, University of Bremen, Germany.
Cancer Genet Cytogenet. 1992 May;60(1):23-6. doi: 10.1016/0165-4608(92)90227-y.
We describe the cytogenetic findings in two benign thyroid hyperplasias with aberrations of chromosome 19. In the first patient, two of four nodules showed identical translocations involving chromosome 19 and 22: 46,XX,der(19)t(19;?)(q13;?),der(22)t(22;?)(q12;?), the remaining nodules had an apparently normal karyotype. Two nodules from a second patient were karyotyped. One showed a karyotype 46,XX,t(1;19)(p35-36.1;q13) and the other had a normal karyotype. From these results as well as those reported previously, we can conclude that structural changes of chromosome 19 characterize a subgroup of thyroid adenomas, thyroid hyperplasias, or both.
我们描述了两例伴有19号染色体畸变的良性甲状腺增生的细胞遗传学发现。在第一例患者中,四个结节中的两个显示出涉及19号和22号染色体的相同易位:46,XX,der(19)t(19;?)(q13;?),der(22)t(22;?)(q12;?),其余结节的核型明显正常。对第二例患者的两个结节进行了核型分析。一个显示核型为46,XX,t(1;19)(p35 - 36.1;q13),另一个核型正常。从这些结果以及先前报道的结果来看,我们可以得出结论,19号染色体的结构变化是甲状腺腺瘤、甲状腺增生或两者的一个亚组的特征。